MT is a competition that originated at the University of Queensland and has since spread to universities around the world.
The University of Nevada, Reno’s CEE Department recognized four graduate researchers at the March 19 Graduate Student ...
WALTHAM, Mass., March 20, 2026 (GLOBE NEWSWIRE)-- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, ...
PHILADELPHIA, March 19, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) ...
For more information and to view the Company’s abstract, visit the AACR Annual Meeting website. The poster will be made available in the Publications section of the Company’s website at the beginning ...
(MENAFN- GlobeNewsWire - Nasdaq) WESTLAKE VILLAGE, Calif., and DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company ...
WESTLAKE VILLAGE, Calif., and DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results